Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05888311
Other study ID # EF 184B
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 30, 2024
Est. completion date August 30, 2024

Study information

Verified date May 2024
Source Eurofarma Laboratorios S.A.
Contact Gleyce Lima
Phone 55 11 5090 8411
Email gleyce.lima@eurofarma.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was designed with the objective of evaluating the protection potential provided by the experimental product (Liquid Bandage) by evaluating its barrier formation capacity. Once the product's ability to form a barrier is confirmed, its ability to protect against small skin injuries, such as small cuts and bruises, blisters and cracks, is confirmed. The barrier formation also guarantees protection against the formation of calluses.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date August 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion criteria - Age between 18 and 70 years old. - Presence of intact skin in the test region (right forearm and left forearm for selected participants). - Agreement to adhere to the study procedures and requirements and attend the institute on the days and times determined for the assessments. - Signing of the Informed Consent Form (ICF) and the Image Disclosure Consent Form (IDCF) before carrying out any study procedure. Exclusion Criteria - Diagnosis of skin diseases such as vitiligo, psoriasis, atopic dermatitis. - Diagnosis of immunological insufficiency. - Use of systemic corticosteroids or immunosuppressants. - Diagnosis of type 1 diabetes mellitus or insulin-dependent diabetes or presence of complications resulting from diabetes (such as retinopathy, nephropathy, neuropathy), presence of diabetes-related dermatoses (such as plantar ulcers, lipoid necrobiosis, granuloma annulare, opportunistic infections), history of episodes of hypoglycemia, diabetic ketoacidosis and/or hyperosmolar coma .

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Liquid bandage
Two areas measuring 3.0 cm x 3.0 cm will be randomly demarcated on one of your forearms, with activated carbon applied to both areas. An area to be treated with the experimental product will be determined by randomization.
Other:
Activated carbon
Two areas measuring 3.0 cm x 3.0 cm will be randomly demarcated on one of your forearms, with activated carbon applied to both areas. An untreated area (control area) will be determined by randomization.

Locations

Country Name City State
Brazil Eurofarma Laboratorios S.A São Paulo

Sponsors (1)

Lead Sponsor Collaborator
Eurofarma Laboratorios S.A.

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Incidence of adverse event and treatment discontinuations due to adverse event. The safety assessment will be based on the safety population, which includes all randomized research participants who receive the first application of the investigational product and who perform at least one safety assessment after randomization 12 hours
Other Incidence of adverse event and treatment discontinuations due to adverse event. The safety assessment will be based on the safety population, which includes all randomized research participants who receive the first application of the investigational product and who perform at least one safety assessment after randomization 24 hours
Primary Average variation in color change in relation to the control area 12 hours after application of the experimental product. Primary efficacy analyzes (barrier formation 12 hours after product application) will be based on the intention-to-treat population, which includes all randomized participants who have data up to at least 12 hours after product application. 12 hours
Secondary Average variation in color change in relation to the control area in 01 washes after applying the experimental product. Secondary efficacy analyzes (resistance to water barrier formation up to 24 hours after product application) will be based on the per-protocol population, which include all randomized participants who present data for all study assessment times without major protocol violations. 1 hours
Secondary Average variation in color change in relation to the control area in 02 washes after applying the experimental product. Secondary efficacy analyzes (resistance to water barrier formation up to 24 hours after product application) will be based on the per-protocol population, which include all randomized participants who present data for all study assessment times without major protocol violations. 2 hours
Secondary Average variation in color change in relation to the control area in 03 washes after applying the experimental product. Secondary efficacy analyzes (resistance to water barrier formation up to 24 hours after product application) will be based on the per-protocol population, which include all randomized participants who present data for all study assessment times without major protocol violations. 3 hours
Secondary Average variation in color change in relation to the control area in 04 washes after applying the experimental product. Secondary efficacy analyzes (resistance to water barrier formation up to 24 hours after product application) will be based on the per-protocol population, which include all randomized participants who present data for all study assessment times without major protocol violations. 4 hours
See also
  Status Clinical Trial Phase
Completed NCT03302559 - Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage N/A
Completed NCT04510103 - A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry Skin N/A
Active, not recruiting NCT04972747 - The Effect of Skin Care Applied With Two Different Oils on Skin Integrity and Growth Parameters in Premature Babies N/A
Completed NCT03640832 - A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin N/A
Completed NCT04557371 - A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. N/A
Completed NCT03824886 - Enhancing SKIN Health and Safety in Aged CARE N/A
Completed NCT03402373 - Evaluation of the Nutritional Supplement Lycoderm on Its Impact on Skin Parameters N/A
Completed NCT03119688 - To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT) N/A
Recruiting NCT05005611 - Probiotics Regulates Skin Care in Children N/A
Recruiting NCT05337670 - Probiotics Regulates Skin Care in Children N/A
Not yet recruiting NCT05876546 - Evaluation of Skin Irritancy and Sensitization of a Liquid Bandage N/A
Completed NCT03233009 - To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test N/A
Completed NCT02106403 - A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray N/A
Active, not recruiting NCT03192592 - Safety and Effectiveness Evaluation of the Apotech® Diabetic Body Moisturizer N/A
Completed NCT03103906 - Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure N/A
Completed NCT03183518 - To Assess the Photosensitisation and Photoallergy Potential of a Cosmetic Facial Product in Healthy Participants N/A
Completed NCT03175562 - To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants N/A
Completed NCT05266209 - Comparison of Coconut and Sunflower Oil Application in Preserving Babies' Skin Integrity N/A
Not yet recruiting NCT05738018 - Evaluating Patient Experiences in Skin Care Clinical Studies
Completed NCT02603029 - Influence of of Cream With the Silver Fir Wood Extract (Belinal) on Skin N/A